- Home
- ISTR vs GOSS Comparison
ISTR vs GOSS Comparison
Compare ISTR & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- GOSS
- Stock Information
- Founded
- ISTR 2006
- GOSS 2015
- Country
- ISTR United States
- GOSS United States
- Employees
- ISTR N/A
- GOSS N/A
- Industry
- ISTR Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- GOSS Health Care
- Exchange
- ISTR Nasdaq
- GOSS Nasdaq
- Market Cap
- ISTR 225.8M
- GOSS 212.8M
- IPO Year
- ISTR 2014
- GOSS 2019
- Fundamental
- Price
- ISTR $18.56
- GOSS $1.40
- Analyst Decision
- ISTR Hold
- GOSS Strong Buy
- Analyst Count
- ISTR 1
- GOSS 5
- Target Price
- ISTR $21.00
- GOSS $9.20
- AVG Volume (30 Days)
- ISTR 33.7K
- GOSS 1.6M
- Earning Date
- ISTR 01-23-2025
- GOSS 03-04-2025
- Dividend Yield
- ISTR 2.26%
- GOSS N/A
- EPS Growth
- ISTR 20.71
- GOSS N/A
- EPS
- ISTR 2.04
- GOSS N/A
- Revenue
- ISTR $86,316,000.00
- GOSS $105,322,000.00
- Revenue This Year
- ISTR N/A
- GOSS N/A
- Revenue Next Year
- ISTR $11.06
- GOSS N/A
- P/E Ratio
- ISTR $9.10
- GOSS N/A
- Revenue Growth
- ISTR 3.92
- GOSS N/A
- 52 Week Low
- ISTR $14.60
- GOSS $0.50
- 52 Week High
- ISTR $24.81
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- ISTR 35.20
- GOSS 67.09
- Support Level
- ISTR $18.52
- GOSS $1.37
- Resistance Level
- ISTR $19.57
- GOSS $1.55
- Average True Range (ATR)
- ISTR 0.50
- GOSS 0.13
- MACD
- ISTR 0.03
- GOSS 0.03
- Stochastic Oscillator
- ISTR 15.84
- GOSS 75.81
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.